These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1999278)

  • 1. Independent effects of youth and poor diabetes control on responses to hypoglycemia in children.
    Jones TW; Boulware SD; Kraemer DT; Caprio S; Sherwin RS; Tamborlane WV
    Diabetes; 1991 Mar; 40(3):358-63. PubMed ID: 1999278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
    Levy CJ; Kinsley BT; Bajaj M; Simonson DC
    Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
    Dagogo-Jack S; Rattarasarn C; Cryer PE
    Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
    Davis MR; Shamoon H
    Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children.
    Amiel SA; Simonson DC; Sherwin RS; Lauritano AA; Tamborlane WV
    J Pediatr; 1987 Jun; 110(6):832-7. PubMed ID: 3585599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Di Vincenzo A; Modarelli F; Ciofetta M; Lepore M; Annibale B; Torlone E
    Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
    Davis MR; Mellman M; Shamoon H
    Diabetes; 1992 Oct; 41(10):1335-40. PubMed ID: 1397708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent hypoglycemia impairs glucose counterregulation.
    Widom B; Simonson DC
    Diabetes; 1992 Dec; 41(12):1597-602. PubMed ID: 1446801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic thresholds for cognitive dysfunction in IDDM.
    Blackman JD; Towle VL; Sturis J; Lewis GF; Spire JP; Polonsky KS
    Diabetes; 1992 Mar; 41(3):392-9. PubMed ID: 1551499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
    Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
    Amiel SA; Sherwin RS; Simonson DC; Tamborlane WV
    Diabetes; 1988 Jul; 37(7):901-7. PubMed ID: 3290007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes.
    ; Tsalikian E; Tamborlane W; Xing D; Becker DM; Mauras N; Fiallo-Scharer R; Buckingham B; Weinzimer S; Steffes M; Singh R; Beck R; Ruedy K; Kollman C
    Diabetes Care; 2009 Nov; 32(11):1954-9. PubMed ID: 19675205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
    Matyka KA; Crowne EC; Havel PJ; Macdonald IA; Matthews D; Dunger DB
    Diabetes Care; 1999 Jul; 22(7):1144-50. PubMed ID: 10388980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
    Kinsley BT; Widom B; Utzschneider K; Simonson DC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1383-9. PubMed ID: 7962332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the late posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Fowelin J; Attvall S; von Schenck H; Smith U; Lager I
    Metabolism; 1990 Aug; 39(8):823-6. PubMed ID: 2198433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM. Effect of glycemic control.
    Kinsley BT; Widom B; Simonson DC
    Diabetes Care; 1995 Jan; 18(1):17-26. PubMed ID: 7698043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes.
    Simonson DC; Tamborlane WV; DeFronzo RA; Sherwin RS
    Ann Intern Med; 1985 Aug; 103(2):184-90. PubMed ID: 3893253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subject.
    Davis SN; Goldstein RE; Cherrington AD; Price L
    Diabetes Res Clin Pract; 1994 Jan; 22(2-3):139-46. PubMed ID: 8200295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.